Stryker has agreed to pay $1.28 billion in an all-cash deal to Bain Capital for automated external defibrillator maker Physio-Control, which was previously sold to Bain by Medtronic for $478 million.
Though it’s not currently finalized, the deal is expected to close by the beginning of the Q2.
Washington-based Physio-Control will be integrated into Stryker’s emergency medical systems portfolio, the company said, according to Mass Device. Physio-Control first introduced its direct current defibrillator more than 55 years ago.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
The company has multiple devices, mostly centered around its LIFEPAK technology, which include those to be used pre-hospital by first responders, at the hospital and some designed for military use.
Here’s a demonstration video (from when Medtronic still owned Physio-Control).